These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12045065)

  • 1. Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
    Esmaeli B; Hortobagyi GN; Esteva FJ; Booser D; Ahmadi MA; Rivera E; Arbuckle R; Delpassand E; Guerra L; Valero V
    Ophthalmology; 2002 Jun; 109(6):1188-91. PubMed ID: 12045065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
    Esmaeli B; Hortobagyi G; Esteva F; Valero V; Ahmadi MA; Booser D; Ibrahim N; Delpassand E; Arbuckle R
    Ann Oncol; 2002 Feb; 13(2):218-21. PubMed ID: 11885997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
    Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
    Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly.
    Ahmadi MA; Esmaeli B
    Arch Ophthalmol; 2001 Dec; 119(12):1802-4. PubMed ID: 11735790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel.
    Esmaeli B; Amin S; Valero V; Adinin R; Arbuckle R; Banay R; Do KA; Rivera E
    J Clin Oncol; 2006 Aug; 24(22):3619-22. PubMed ID: 16877729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
    Esmaeli B; Valero V; Ahmadi MA; Booser D
    Ophthalmology; 2001 May; 108(5):994-5. PubMed ID: 11320034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa.
    Esmaeli B; Burnstine MA; Ahmadi MA; Prieto VG
    Ophthalmic Plast Reconstr Surg; 2003 Jul; 19(4):305-8. PubMed ID: 12878879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity.
    Tsalic M; Gilboa M; Visel B; Miller B; Haim N
    Med Oncol; 2006; 23(1):57-61. PubMed ID: 16645230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1.
    Esmaeli B; Golio D; Lubecki L; Ajani J
    Am J Ophthalmol; 2005 Aug; 140(2):325-7. PubMed ID: 16086962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
    Tu AH; Chang EL
    Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-associated epiphora.
    Kintzel PE; Michaud LB; Lange MK
    Pharmacotherapy; 2006 Jun; 26(6):853-67. PubMed ID: 16716138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel secretion in tears: association with lacrimal drainage obstruction.
    Esmaeli B; Ahmadi MA; Rivera E; Valero V; Hutto T; Jackson DM; Newman RA
    Arch Ophthalmol; 2002 Sep; 120(9):1180-2. PubMed ID: 12215091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of excessive tearing as a side effect of docetaxel.
    Esmaeli B
    Clin Breast Cancer; 2005 Feb; 5(6):455-7. PubMed ID: 15748466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction.
    Mansur C; Pfeiffer ML; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):9-12. PubMed ID: 27429222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erosive conjunctivitis and punctal stenosis secondary to docetaxel (taxotere).
    Skolnick CA; Doughman DJ
    Eye Contact Lens; 2003 Apr; 29(2):134-5. PubMed ID: 12695719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canalicular stenosis as the underlying mechanism for epiphora in patients receiving weekly docetaxel.
    Esmaeli B; Hortobagyi GN
    Oncologist; 2001; 6(6):551-2. PubMed ID: 11743218
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.
    Esteva FJ; Valero V; Booser D; Guerra LT; Murray JL; Pusztai L; Cristofanilli M; Arun B; Esmaeli B; Fritsche HA; Sneige N; Smith TL; Hortobagyi GN
    J Clin Oncol; 2002 Apr; 20(7):1800-8. PubMed ID: 11919237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of punctal and canalicular stenosis in patients on systemic 5-FU.
    Fezza JP; Wesley RE; Klippenstein KA
    Ophthalmic Surg Lasers; 1999 Feb; 30(2):105-8. PubMed ID: 10037204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balloon canaliculoplasty for acquired canalicular stenosis.
    Zoumalan CI; Maher EA; Lelli GJ; Lisman RD
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):459-61. PubMed ID: 20871460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.